IMMUNOBIOLOGY LIMITED

03777578
Active Cambridge

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

IMMUNOBIOLOGY LIMITED

03777578

Research and experimental development on biotechnology

Founded 26 May 1999 Active Cambridge, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 3 Jul 2026 Next due 28 Feb 2026 5 months overdue
Confirmation Submitted 6 May 2026 Next due 13 Mar 2027 8 months remaining
Net assets £-172K £39K 2024 year on year
Total assets £15K £39K 2024 year on year
Total Liabilities £186K £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Babraham Research Campus Babraham Cambridge CB22 3AT

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IMMUNOBIOLOGY LIMITED (03777578), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 26 May 1999. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jun → 31 May 2024
Type micro-entity
Next accounts 31 May 2025
Due by 28 Feb 2026 5 months overdue

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Decreased by £52.10k (-100%)

Net Assets

-£171.66k

Decreased by £39.23k (-30%)

Total Liabilities

£186.28k

Turnover

N/A

Employees

3

Debt Ratio

1274%

Increased by 928 (+268%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 May Year End
2023
31 May Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 2Nov 2005Seed
Investor 1Oct 2012Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 170,200,120 Shares £29429460.29m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 May 202513,999,999£2.10m£0.15
13 May 202513,999,999£2.10m£0.15
7 Feb 20207,500,000£150k£0.02
12 Mar 201920,100,000£201k£0.01
29 May 201866,000,000£330k£0.005

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (50)

Oxford Technology 2 Vct Plc
11.5%
26,700,000
British Smaller Companies Vct2 Plc
11.5%
26,700,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Mark Robert Blandford

British

Active
Notified 12 Mar 2019
Residence United Kingdom
DOB November 1957
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Rockridge Investments, S.a

Ceased 6 Apr 2016

Ceased

Group Structure

Group Structure

IMMUNOBIOLOGY LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Jul 2026AccountsAnnual accounts made up to 31 May 2025
30 Jun 2026AddressChange Registered Office Address Company With Date Old Address New Address
30 Jun 2026OfficersChange to director Mr Graham John Clarke on 30 Jun 2026
9 May 2026GazetteGazette Filings Brought Up To Date
6 May 2026Confirmation StatementConfirmation statement made on 27 Feb 2026 with updates
3 Jul 2026 Accounts

Annual accounts made up to 31 May 2025

30 Jun 2026 Address

Change Registered Office Address Company With Date Old Address New Address

30 Jun 2026 Officers

Change to director Mr Graham John Clarke on 30 Jun 2026

9 May 2026 Gazette

Gazette Filings Brought Up To Date

6 May 2026 Confirmation Statement

Confirmation statement made on 27 Feb 2026 with updates

Recent Activity

Latest Activity

Annual accounts made up to 31 May 2025

2 days ago on 3 Jul 2026

Change Registered Office Address Company With Date Old Address New Address

5 days ago on 30 Jun 2026

Change to director Mr Graham John Clarke on 30 Jun 2026

5 days ago on 30 Jun 2026

Gazette Filings Brought Up To Date

1 months ago on 9 May 2026

Confirmation statement made on 27 Feb 2026 with updates

2 months ago on 6 May 2026